NASDAQ:ALBT Avalon GloboCare (ALBT) Stock Price, News & Analysis → Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad) Free ALBT Stock Alerts $0.25 -0.01 (-3.90%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$0.24▼$0.2750-Day Range$0.26▼$0.4252-Week Range$0.24▼$2.42Volume30,953 shsAverage Volume131,169 shsMarket Capitalization$2.74 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Avalon GloboCare alerts: Email Address Ad Paradigm PressNever use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here About Avalon GloboCare Stock (NASDAQ:ALBT)Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing mRNA-based Flash-CAR cell therapy platform. In addition, the company develops Avalon clinical-grade tissue-specific exosome (ACTEX); AVA-Trap, a therapeutic program provides an effective therapeutic option to combat COVID-19 and other life-threatening conditions involving cytokine storms; offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Avalon GloboCare Corp. has strategic partnership with HydroPeptide, LLC to engage in co-development and commercialization of a series of clinical-grade, exosome-based cosmeceutical, and orthopedic products; and corporate research agreement with the University of Pittsburgh of the Commonwealth System of Higher Education. The company was founded in 2016 and is headquartered in Freehold, New Jersey.Read More ALBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ALBT Stock News HeadlinesApril 27, 2024 | americanbankingnews.comAvalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Increase in Short InterestApril 25, 2024 | finance.yahoo.comAvalon GloboCare Corp. (ALBT)May 4, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. April 23, 2024 | proactiveinvestors.comAvalon GloboCare launches KetoAir breathalyzer in the USApril 22, 2024 | globenewswire.comAvalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 ConferenceApril 16, 2024 | msn.comALBT Stock Earnings: Avalon Globocare Reported Results for Q4 2023March 28, 2024 | proactiveinvestors.comAvalon GloboCare extends exclusive distribution agreement for KetoAir breathalyzerMarch 28, 2024 | globenewswire.comAvalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European UnionMay 4, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. December 18, 2023 | finance.yahoo.comAvalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the USNovember 16, 2023 | morningstar.comAvalon Globocare Corp ALBTOctober 18, 2023 | finance.yahoo.comAvalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic KetoacidosisOctober 6, 2023 | benzinga.comApple Approves Use of Avalon GloboCare's KetoAir Mobile ApplicationOctober 6, 2023 | finance.yahoo.comShareholders May Be A Bit More Conservative With Avalon GloboCare Corp.'s (NASDAQ:ALBT) CEO Compensation For NowOctober 4, 2023 | proactiveinvestors.comAvalon GloboCare debuts KetoAir app on Apple App StoreOctober 4, 2023 | finance.yahoo.comApple Approves Use of Avalon GloboCare’s KetoAir Mobile ApplicationSeptember 27, 2023 | theglobeandmail.comNews Brief: Avalon GloboCare Corp.September 13, 2023 | proactiveinvestors.comAvalon GloboCare shares spike on Laboratory Services MSO acquisitionsSeptember 5, 2023 | proactiveinvestors.comAvalon GloboCare shares surge as recent momentum continuesAugust 30, 2023 | ca.finance.yahoo.comStocks in play: Avalon GloboCare Corp.August 30, 2023 | proactiveinvestors.comAvalon GloboCare investee LSM launches innovative lab test for tuberculosisAugust 30, 2023 | finance.yahoo.comEXCLUSIVE: Diagnostics Provider Avalon GloboCare's Subsidiary Launches New Laboratory Test For TuberculosisAugust 21, 2023 | proactiveinvestors.comAvalon GloboCare announces Laboratory Services MSO’s expansion into Arizona; shares riseAugust 21, 2023 | proactiveinvestors.comAvalon GloboCare announces Laboratory Services MSO’s expansion into ArizonaAugust 21, 2023 | finance.yahoo.comAvalon’s Laboratory Services MSO Announces Expansion into ArizonaAugust 16, 2023 | finance.yahoo.comAvalon GloboCare Second Quarter 2023 Earnings: US$0.25 loss per share (vs US$0.23 loss in 2Q 2022)July 24, 2023 | proactiveinvestors.comAvalon GloboCare investee buys Houston-based lab testing facilitySee More Headlines Receive ALBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avalon GloboCare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/15/2024Today5/04/2024Next Earnings (Estimated)5/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:ALBT CUSIPN/A CIK1630212 Webwww.avalon-globocare.com Phone(732) 780-4400Fax732-780-5600Employees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.57) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,710,000.00 Net Margins-1,304.14% Pretax Margin-1,330.18% Return on EquityN/A Return on Assets-58.40% Debt Debt-to-Equity RatioN/A Current Ratio0.13 Quick Ratio0.13 Sales & Book Value Annual Sales$1.26 million Price / Sales2.17 Cash FlowN/A Price / Cash FlowN/A Book Value($1.15) per share Price / Book-0.21Miscellaneous Outstanding Shares11,100,000Free Float3,998,000Market Cap$2.74 million OptionableNot Optionable Beta0.30 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. David K. Jin M.D. (Age 56)Ph.D., CEO, President & Director Comp: $330kMs. Luisa Ingargiola (Age 57)Chief Financial Officer Comp: $350kMs. Meng Li (Age 46)COO, Chief Marketing Officer & Secretary Comp: $280.24kKey CompetitorsEloxx PharmaceuticalsNASDAQ:ELOXKiromic BioPharmaNASDAQ:KRBPGamida CellNASDAQ:GMDAQGamida CellNASDAQ:GMDAFinch Therapeutics GroupNASDAQ:FNCHView All Competitors ALBT Stock Analysis - Frequently Asked Questions How have ALBT shares performed in 2024? Avalon GloboCare's stock was trading at $0.4830 at the start of the year. Since then, ALBT stock has decreased by 48.9% and is now trading at $0.2466. View the best growth stocks for 2024 here. Are investors shorting Avalon GloboCare? Avalon GloboCare saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 137,400 shares, an increase of 64.7% from the March 31st total of 83,400 shares. Based on an average trading volume of 170,800 shares, the days-to-cover ratio is currently 0.8 days. Currently, 2.8% of the shares of the company are sold short. View Avalon GloboCare's Short Interest. When is Avalon GloboCare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024. View our ALBT earnings forecast. How were Avalon GloboCare's earnings last quarter? Avalon GloboCare Corp. (NASDAQ:ALBT) released its quarterly earnings results on Monday, April, 15th. The company reported ($0.90) earnings per share (EPS) for the quarter. The firm had revenue of $0.32 million for the quarter. When did Avalon GloboCare's stock split? Avalon GloboCare shares reverse split before market open on Tuesday, January 3rd 2023. The 1-10 reverse split was announced on Tuesday, January 3rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Avalon GloboCare? Shares of ALBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ALBT) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalon GloboCare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.